Skip to content

Removal of Massive Subretinal Organized Blood Clot With Fragmatome

Removal of Massive Subretinal Organized Blood Clot With Fragmatome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04196049
Enrollment
3
Registered
2019-12-12
Start date
2019-01-07
Completion date
2019-11-29
Last updated
2019-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration

Keywords

organized blood clot, fragmatome, exudative age related macular denegeration

Brief summary

By using the ultrasound power delivered by fragmatome, the hard, organized blood clot could be removed easily.

Interventions

PROCEDUREfragmatome

Patients with massive subretinal hemorrhage from age related macular degeneration and organized subretinal blood clot were managed by inferior retinectomy. The subretinal organized blood clot was dragged to the preretinal space and removed by fragmatome. The retinal was reattached with perfluorocarbon liquid and laser was applied at the margin of retinectomy. Silicon oil was infused at the end of surgery.

Sponsors

Changhua Christian Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with massive subretinal hemorrhage from age related macular degeneration * Patients had organized subretinal blood clot were managed by inferior retinectomy.

Exclusion criteria

* Patients without massive subretinal hemorrhage * Patients were not age related macular degeneration.

Design outcomes

Primary

MeasureTime frameDescription
Visual acuityBefore operation, 1 weeks after operation, 1 month after operation.visual acuity change in logMAR in different time point
spherical equivalentBefore operationspherical power + half of cylinder power

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026